Management of lower urinary tract symptoms of eldery men in Austria

European Urology

Volumn 39, Issue 2, 2001, Pages 145-150

  Madersbacher, Stephan ^a   Haidinger, Gerald ^b   Struhal, Gerhard ^c  

^a UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c Hartmannspital   (Austria)

Author keywords

Austria, lower urinary tract symptoms; Benign prostatic hyperplasia; Epidemiology; Medical therapy; Surgical therapy

Indexed keywords

ALFUZOSIN; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; DOXAZOSIN; FINASTERIDE; PLANT EXTRACT; TAMSULOSIN; TERAZOSIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; AUSTRIA; BLADDER NECK STENOSIS; CONTROLLED STUDY; DRUG MARKETING; DRUG UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; TRANSURETHRAL RESECTION;

AGE FACTORS; AGED; AUSTRIA; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PROSTATIC HYPERPLASIA; URINATION DISORDERS;

EID: 0035108068     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1159/000052429     Document Type: Article

References (16)

1. Introduction and concluding remarks
2. Management of symptomatic BPH in the US: Who is treated and how?
3. Management of symptomatic BPH in France: Who is treated and how?
4. Management of the BPH syndrome in Germany: Who is treated and how?
5. Management of symptomatic BPH in Italy: Who is treated and how?
6. Management of symptomatic BPH in the UK: Who is treated and how?
7. Is TURP still justified?
8. High prevalence of benign prostatic hypertrophy in the community
9. The prevalence of prostatism: A population-based survey of urinary symptoms
10. Prevalence and detection of micturition problems among 2,734 elderly men
11. The prevalence of lower urinary tract symptoms in Austria as assessed by an open survey of 2,096 men
12. The prevalence of lower urinary tract symptoms in Austrian males and associations with sociodemographic variables
13. The natural history of patients with benign prostatic hyperplasia as diagnosed by North American urologists
14. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia
15. Long-term effects of finasteride in patients with benign prostatic hyperplasia: A double-blind, placebo-controlled, multicenter study
16. Minimally invasive therapy in BPH